Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke (Strokeback01)
Primary Purpose
Acute Ischaemic Stroke, Autonomic Dysfunction
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Biofeedback
Sham-Biofeedback
Sponsored by
About this trial
This is an interventional other trial for Acute Ischaemic Stroke focused on measuring Ischaemic Stroke, Heart Rate Variability, Autonomic Nervous System, cardiac autonomic dysfunction, sudomotor function, vasomotor function
Eligibility Criteria
Inclusion Criteria:
- male and female subjects aged between 18 and 90
- written and oral informed consent
- evidence of an ischaemic lesion on cranial computed tomography scan or magnetic resonance imaging
Exclusion Criteria:
- intake of any tricyclic antidepressant within the last 14 days
- atrial fibrillation
- prior diagnosed autonomic neuropathy
- malignant cerebral infarct or indication for treatment at intensive care unit
- aphasia or cognitive deficit with resulted inability to participate in Heart rate variability-biofeedback training
- respiratory insufficiency
- blindness, deafness or other physical limitations with resulted inability to participate in heart rate variability-biofeedback training
Sites / Locations
- Department of Neurology, University Hospital Carl Gustav Carus Dresden, Germany
Arms of the Study
Arm 1
Arm 2
Arm Type
Sham Comparator
Active Comparator
Arm Label
Control group acute ischaemic stroke
Treatment group acute ischaemic stroke
Arm Description
Acute ischaemic stroke patients receiving 9 x 10 minutes sham-biofeedback over a period of three days
Acute ischaemic stroke patients receiving 9 x 10 minutes biofeedback sessions over period of three days
Outcomes
Primary Outcome Measures
Heart rate variability in acute ischaemic stroke patients
Measurement of heart rate variability in acute ischaemic stroke patients
Severity of autonomic symptoms
Assessment of autonomic symptoms with Survey of Autonomic Symptoms
Measurement of sudomotor and vasomotor function
Assessment of sudomotor and vasomotor function in patients with acute ischaemic stroke prior and after intervention
Secondary Outcome Measures
Severity of neurological stroke symptoms
Assessment of severity of neurological symptoms in patients with acute ischaemic stroke with the National Institutes of Health Stroke Scale (range from 0 to 42)
Degree of disability in patients with acute ischemic stroke
Assessment of functional outcome as the degree of disability in patients with acute ischaemic stroke with the modified Rankin Scale (range from 0 to 6)
Full Information
NCT ID
NCT03865225
First Posted
March 3, 2019
Last Updated
January 9, 2021
Sponsor
Technische Universität Dresden
Collaborators
Michael J. Fox Foundation for Parkinson's Research, University Hospital Carl Gustav Carus
1. Study Identification
Unique Protocol Identification Number
NCT03865225
Brief Title
Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke
Acronym
Strokeback01
Official Title
Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischaemic Stroke: Protocol for Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
November 25, 2018 (Actual)
Primary Completion Date
August 1, 2019 (Actual)
Study Completion Date
November 1, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Technische Universität Dresden
Collaborators
Michael J. Fox Foundation for Parkinson's Research, University Hospital Carl Gustav Carus
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This explorative prospective study aims to assess the effects of heart rate variability biofeedback (HRV biofeedback) in patients with acute ischaemic stroke. Furthermore, the investigators aim to examine the impact of the intervention on cardiac autonomic function and further autonomic parameters such as sudomotor (sympathetic perspiratory gland function) and vasomotor function (sympathetic arterial function). Patients testing is going to be conducted at the Department of Neurology, University Hospital Carl Gustave Carus, Dresden, Germany.
Detailed Description
Background:
Ischaemic stroke is among the most common causes for severe disability and death in the industrialized world with steadily increasing prevalence due to the demographic change. Thus more than 795,000 people yearly have a stroke in the United States of America, of which circa 610,000 people have new strokes or a stroke for the first time in their life (Benjamin, et al. 2017). Symptoms of ischaemic stroke patients include dysregulation of the autonomic nervous system such as cardiac and vascular autonomic dysfunction, which correlate with increased mortality and poor functional outcome. This study aims to assess the effects of heart rate variability biofeedback (HRV-Biofeedback) in patients with acute ischaemic stroke. Furthermore, the investigators aim to examine the impact of the intervention on cardiac autonomic function and further autonomic parameters such as sudomotor (sympathetic perspiratory gland function) and vasomotor function (sympathetic arterial function).
Methods/design:
An explorative prospective study is undertaken in 48 patients with acute ischaemic stroke who undergo either 9 x 10-minutes lasting biofeedback sessions over a period of 3 days, or sham-biofeedback (control-group) also over a period of 3 days under randomized controlled conditions.
The HRV-biofeedback technique is based on the recording and visualization of heart rate variability, which is visible in real-time for the patient on a computer screen. In the training sessions, the patient is instructed to breath in a predefined frequency, which has been shown to yield optimal neurologic-cardiac regulation (respiratory sinus arrhythmia) with high heart rate variability. Sham-biofeedback takes place under identical testing and environmental conditions with subjects looking at a computer screen but not having heart rate variability recorded and visualized. Moreover, the patients do not follow any breathing instructions, which could possibly have any influence on the heart rate variability. The sham intervention is applied to rule out any placebo effect.
Before the first and after the last biofeedback-session, measurements of heart rate variability and polygraphical recordings of further autonomic functions (sudomotor function and vasomotor function) are undertaken. Severity of the autonomic functions is captured by a specific survey (Survey of Autonomic Symptoms). The modified Rankin Scale is used to assess functional outcome after acute ischaemic stroke at baseline, with the conclusion of the biofeedback-sessions, and in the context of a telephone-interview after a period of 3 months. Furthermore, severity of common stroke related symptoms is recorded at baseline and after the last training session using the National Institutes of Health Stroke Scale. All assessments as well as all biofeedback training sessions take place at the Stroke Unit of the Department of Neurology, University Hospital Carl Gustave Carus Dresden, Germany.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Ischaemic Stroke, Autonomic Dysfunction
Keywords
Ischaemic Stroke, Heart Rate Variability, Autonomic Nervous System, cardiac autonomic dysfunction, sudomotor function, vasomotor function
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Sham biofeedback intervention
Allocation
Randomized
Enrollment
48 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control group acute ischaemic stroke
Arm Type
Sham Comparator
Arm Description
Acute ischaemic stroke patients receiving 9 x 10 minutes sham-biofeedback over a period of three days
Arm Title
Treatment group acute ischaemic stroke
Arm Type
Active Comparator
Arm Description
Acute ischaemic stroke patients receiving 9 x 10 minutes biofeedback sessions over period of three days
Intervention Type
Other
Intervention Name(s)
Biofeedback
Intervention Description
9 x 10 minutes biofeedback sessions over period of three days
Intervention Type
Other
Intervention Name(s)
Sham-Biofeedback
Intervention Description
9 x 10 minutes sham-biofeedback sessions over period of three days
Primary Outcome Measure Information:
Title
Heart rate variability in acute ischaemic stroke patients
Description
Measurement of heart rate variability in acute ischaemic stroke patients
Time Frame
Change from Baseline Heart rate variability at 3 days
Title
Severity of autonomic symptoms
Description
Assessment of autonomic symptoms with Survey of Autonomic Symptoms
Time Frame
Change from Baseline Severity of autonomic symptoms at 3 days and at 3 months
Title
Measurement of sudomotor and vasomotor function
Description
Assessment of sudomotor and vasomotor function in patients with acute ischaemic stroke prior and after intervention
Time Frame
Change from Baseline Measurement of sudomotor and vasomotor function at 3 days
Secondary Outcome Measure Information:
Title
Severity of neurological stroke symptoms
Description
Assessment of severity of neurological symptoms in patients with acute ischaemic stroke with the National Institutes of Health Stroke Scale (range from 0 to 42)
Time Frame
Change from Baseline Severity of neurological stroke symptoms at 3 days
Title
Degree of disability in patients with acute ischemic stroke
Description
Assessment of functional outcome as the degree of disability in patients with acute ischaemic stroke with the modified Rankin Scale (range from 0 to 6)
Time Frame
Change from Baseline Functional Outcome at 3 days and at 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
male and female subjects aged between 18 and 90
written and oral informed consent
evidence of an ischaemic lesion on cranial computed tomography scan or magnetic resonance imaging
Exclusion Criteria:
intake of any tricyclic antidepressant within the last 14 days
atrial fibrillation
prior diagnosed autonomic neuropathy
malignant cerebral infarct or indication for treatment at intensive care unit
aphasia or cognitive deficit with resulted inability to participate in Heart rate variability-biofeedback training
respiratory insufficiency
blindness, deafness or other physical limitations with resulted inability to participate in heart rate variability-biofeedback training
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Timo Siepmann, PD, MD
Organizational Affiliation
University Hospital Carl Gustav Carus Dresden, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Neurology, University Hospital Carl Gustav Carus Dresden, Germany
City
Dresden
State/Province
Saxony
ZIP/Postal Code
01307
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
28122885
Citation
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. No abstract available. Erratum In: Circulation. 2017 Mar 7;135(10 ):e646. Circulation. 2017 Sep 5;136(10 ):e196.
Results Reference
background
PubMed Identifier
34122314
Citation
Siepmann T, Ohle P, Sedghi A, Simon E, Arndt M, Pallesen LP, Ritschel G, Barlinn J, Reichmann H, Puetz V, Barlinn K. Randomized Sham-Controlled Pilot Study of Neurocardiac Function in Patients With Acute Ischaemic Stroke Undergoing Heart Rate Variability Biofeedback. Front Neurol. 2021 May 26;12:669843. doi: 10.3389/fneur.2021.669843. eCollection 2021.
Results Reference
derived
Learn more about this trial
Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke
We'll reach out to this number within 24 hrs